Balance Sheets
Condolidated Balance Sheets
(Billions of yen)
(Millions of yen)
 
| YEARS ENDED MARCH 31 | 
2021/3 | 
2022/3 | 
2023/3 | 
2024/3 | 
2025/3 | 
| Assets | 
| Current assets: | 
629,207 | 
681,981 | 
713,553 | 
763,072 | 
766,672 | 
| - Cash and time deposits | 
76,546 | 
92,966 | 
84,700 | 
66,186 | 
63,542 | 
| - Notes and accounts receivable, trade | 
319,644 | 
357,341 | 
388,499 | 
430,128 | 
417,797 | 
| - Inventories | 
183,190 | 
170,295 | 
198,691 | 
226,135 | 
238,650 | 
| - Other current assets | 
49,826 | 
61,378 | 
41,662 | 
40,620 | 
46,682 | 
| Long-term assets: | 
422,652 | 
435,058 | 
467,946 | 
508,064 | 
545,435 | 
| - Tangible fixed assets | 
209,758 | 
233,675 | 
283,912 | 
311,456 | 
347,074 | 
| - Intangible fixed assets | 
23,426 | 
22,504 | 
24,032 | 
25,462 | 
30,318 | 
| - Investments and other assets | 
189,468 | 
178,878 | 
160,001 | 
171,145 | 
168,042 | 
| Deferred assets | 
92 | 
71 | 
51 | 
37 | 
67 | 
| Total assets | 
1,051,952 | 
1,117,112 | 
1,181,552 | 
1,271,174 | 
1,312,175 | 
| Liabilities and shareholders' equity | 
| Current liabilities: | 
356,416 | 
386,969 | 
446,826 | 
475,342 | 
431,466 | 
| - Notes and accounts payable, trade | 
167,260 | 
171,749 | 
201,593 | 
207,408 | 
192,834 | 
| - Short-term loans | 
21,744 | 
44,984 | 
46,875 | 
40,259 | 
10,716 | 
| - Current portion of debentures | 
 | 
 | 
15,000 | 
 | 
 | 
| - Other current liabilities | 
167,411 | 
170,236 | 
183,357 | 
227,674 | 
227,916 | 
| Long-term liabilities | 
234,281 | 
206,413 | 
162,657 | 
134,359 | 
150,050 | 
| - Long-term debt and bonds | 
131,686 | 
101,276 | 
48,600 | 
35,100 | 
60,073 | 
| - Net defined benefit liability | 
53,322 | 
57,590 | 
60,345 | 
63,803 | 
66,797 | 
| - Other long-term liabilities | 
49,272 | 
47,545 | 
53,711 | 
35,455 | 
23,179 | 
| Total liabilities | 
590,698 | 
593,382 | 
609,483 | 
609,701 | 
581,517 | 
| Net Assets | 
| Shareholders' equity: | 
358,021 | 
405,467 | 
451,091 | 
509,278 | 
601,771 | 
| - Common stock | 
47,586 | 
47,586 | 
47,586 | 
47,586 | 
47,586 | 
| - Capital surplus | 
46,003 | 
45,955 | 
45,953 | 
45,954 | 
64,573 | 
| - Retained earnings | 
271,772 | 
319,285 | 
364,922 | 
423,135 | 
493,885 | 
| - Treasury stock at cost | 
-7,340 | 
-7,359 | 
-7,370 | 
-7,397 | 
-4,273 | 
| Valuation and translation adjustments: | 
58,975 | 
67,433 | 
66,000 | 
93,237 | 
89,995 | 
| - Unrealized gain on other securities | 
55,761 | 
51,649 | 
45,550 | 
54,717 | 
49,318 | 
| - Deferred gain on hedges | 
322 | 
507 | 
241 | 
-35 | 
-2 | 
| - Foreign currency transaction adjustment | 
1,539 | 
14,169 | 
22,222 | 
37,772 | 
40,046 | 
| - Remeasurements of defined benefit plans | 
1,351 | 
1,107 | 
-2,013 | 
782 | 
633 | 
| Minority interests in consolidated subsidiaries | 
3,415 | 
5,894 | 
7,285 | 
6,717 | 
4,441 | 
| Total net assets | 
461,254 | 
523,729 | 
572,068 | 
661,472 | 
730,658 | 
| Total liabilities and net assets | 
1,051,952 | 
1,117,112 | 
1,181,552 | 
1,271,174 | 
1,312,175 | 
 
 
 
 
 
Income Statement / Statement of Comprehensive Income
Consolidated Statements of Income
(Billions of yen)
(Millions of yen)
| YEARS ENDED MARCH 31 | 
2021/3 | 
2022/3 | 
2023/3 | 
2024/3 | 
2025/3 | 
| Net sales | 
875,927 | 
910,226 | 
1,009,447 | 
1,103,214 | 
1,123,407 | 
| Cost of sales | 
654,661 | 
657,789 | 
732,528 | 
799,925 | 
805,505 | 
| - Gross profit | 
221,266 | 
252,436 | 
276,918 | 
303,289 | 
317,901 | 
| - Ratio to net sales (%) | 
25.3 | 
27.7 | 
27.4 | 
27.5 | 
28.3 | 
| Selling, general and administration | 
172,670 | 
177,601 | 
188,036 | 
197,222 | 
200,254 | 
| - Operating income (loss) | 
48,595 | 
74,835 | 
88,882 | 
106,066 | 
117,646 | 
| - Ratio to net sales (%) | 
5.5 | 
8.2 | 
8.8 | 
9.6 | 
10.5 | 
| Non-operating income | 
5,951 | 
7,329 | 
5,927 | 
7,903 | 
7,269 | 
| - Interest and dividends received | 
2,955 | 
2,885 | 
3,742 | 
3,346 | 
3,475 | 
| - Other | 
2,995 | 
4,444 | 
2,185 | 
4,557 | 
3,793 | 
| Non-operating expenses | 
4,146 | 
2,867 | 
6,997 | 
6,147 | 
6,156 | 
| - Interest expense | 
1,441 | 
1,744 | 
1,993 | 
2,101 | 
3,335 | 
| - Other | 
2,704 | 
1,122 | 
5,004 | 
4,046 | 
2,821 | 
| - Ordinary income (loss) | 
50,401 | 
79,297 | 
87,811 | 
107,822 | 
118,759 | 
| - Ratio to net sales (%) | 
5.8 | 
8.7 | 
8.7 | 
9.8 | 
10.6 | 
| Extraordinary income | 
41,145 | 
10,538 | 
11,154 | 
8,554 | 
19,777 | 
| Extraordinary loss | 
28,262 | 
1,349 | 
3,220 | 
2,344 | 
4,874 | 
| - Income before income taxes | 
63,284 | 
88,487 | 
95,746 | 
114,032 | 
133,661 | 
| - Income taxes and business tax (%) | 
7.2 | 
9.7 | 
9.5 | 
10.3 | 
11.9 | 
| Income taxes and business tax | 
21,423 | 
21,846 | 
26,317 | 
32,118 | 
41,750 | 
| Deferred income taxes | 
-3,481 | 
2,085 | 
794 | 
-156 | 
-4,770 | 
| Income before minority interests | 
45,342 | 
64,555 | 
68,634 | 
82,070 | 
96,681 | 
| Profit attributable to non-controlling interests | 
3,415 | 
5,894 | 
7,285 | 
6,717 | 
4,441 | 
| - Profit (loss) attributable to owners of parent | 
41,926 | 
58,660 | 
61,348 | 
75,353 | 
92,239 | 
| - Ratio to net sales (%) | 
4.8 | 
6.4 | 
6.1 | 
6.8 | 
8.2 | 
 
 
 
 
Consolidated Statements of Comprehensive Income
(Millions of yen)
| YEARS ENDED MARCH 31 | 
2021/3 | 
2022/3 | 
2023/3 | 
2024/3 | 
2025/3 | 
| Income before minority interests | 
45,342 | 
64,555 | 
68,634 | 
82,070 | 
96,681 | 
| Other comprehensive income (loss) | 
Valuation differences on available-for-sale securities | 
11,400 | 
-4,222 | 
-6,202 | 
8,871 | 
-5,432 | 
| Deferred gains or loss on hedges | 
553 | 
185 | 
-265 | 
-277 | 
32 | 
| Foreign currency translation adjustments | 
5,935 | 
13,985 | 
8,176 | 
16,456 | 
2,253 | 
| Remeasurements of defined benefit plans net of tax | 
4,419 | 
-37 | 
-3,279 | 
2,804 | 
-832 | 
| Share of other comprehensive income (loss) of associates accounted for using equity method | 
-215 | 
20 | 
54 | 
432 | 
344 | 
| Total other comprehensive loss | 
22,094 | 
9,930 | 
-1,516 | 
28,288 | 
-3,634 | 
| Comprehensive income (loss) | 
67,437 | 
74,485 | 
67,117 | 
110,358 | 
93,046 | 
| Comprehensive income (loss) Attributable to: | 
Comprehensive income attributable to owners of parent | 
62,796 | 
67,118 | 
59,915 | 
102,590 | 
88,998 | 
| Comprehensive income attributable to non-controlling interests | 
4,640 | 
7,367 | 
7,202 | 
7,768 | 
4,048 | 
 
 
 
 
 
Cash Flows
Consolidated Statements of Cash Flows
(Billions of yen)
(Millions of yen)
 
| YEARS ENDED MARCH 31 | 
2021/3
 | 2022/3
 | 2023/3
 | 2024/3
 | 2025/3
 | 
| Cash flows from operating activities: | 
| Income (loss) before income taxes | 
63,284 | 
88,487 | 
95,746 | 
114,032 | 
133,661 | 
| Depreciation and amortization | 
36,194 | 
39,969 | 
45,938 | 
51,875 | 
57,341 | 
| Interest and dividends income | 
-2,955 | 
-2,885 | 
-3,742 | 
-3,346 | 
-3,475 | 
| Interest expense | 
1,441 | 
1,744 | 
1,993 | 
2,101 | 
3,335 | 
| (Increase) decrease in trade receivables, and contract assets | 
-20,852 | 
-749 | 
-28,444 | 
-35,699 | 
11,770 | 
| (Increase) decrease in inventories | 
7,513 | 
-5,707 | 
-25,709 | 
-21,360 | 
-11,670 | 
| Increase (decrease) in trade payables | 
-15,881 | 
-2,623 | 
28,711 | 
3,516 | 
-14,999 | 
| Increase (decrease) in advances received | 
-12,185 | 
9,339 | 
9,748 | 
4,357 | 
12,104 | 
| Other, net | 
-20,796 | 
-26,744 | 
13,366 | 
-407 | 
-12,672 | 
| Subtotal | 
35,762 | 
100,829 | 
137,607 | 
115,068 | 
175,395 | 
| Interest and dividends received | 
2,959 | 
2,847 | 
3,679 | 
3,438 | 
3,474 | 
| Interest paid | 
-1,416 | 
-1,738 | 
-1,996 | 
-2,166 | 
-3,286 | 
| Income taxes paid | 
-10,374 | 
-25,129 | 
-23,126 | 
-31,481 | 
-33,662 | 
| Settlement received | 
 | 
 | 
 | 
 | 
3,000 | 
| Net cash provided by (used in) operating activities | 
26,931 | 
76,809 | 
116,163 | 
84,858 | 
144,920 | 
| Cash flows from investing activities: | 
| Purchase of fixed assets and marketable and investment securities | 
-20,607 | 
-34,957 | 
-61,293 | 
-67,279 | 
-77,025 | 
| Proceeds from sale of fixed assets and marketable and investment securities | 
49,852 | 
21,171 | 
20,541 | 
12,808 | 
18,760 | 
| Other, net | 
-5,767 | 
-8,564 | 
-8,746 | 
-7,948 | 
-5,118 | 
| Net cash provided by (used in) investing activities | 
23,477 | 
-22,350 | 
-49,498 | 
-62,418 | 
-63,384 | 
| Free cash flows | 
50,408 | 
54,458 | 
66,665 | 
22,439 | 
81,536 | 
| Cash flows from financing activities: | 
| Increase (decrease) in short-term borrowings, net | 
-2,678 | 
-3,592 | 
-6,002 | 
2,023 | 
-1,247 | 
| Increase (decrease) in commercial paper, net | 
-51,500 | 
 | 
 | 
36,000 | 
-36,000 | 
| Proceeds from long-term debt | 
62,165 | 
 | 
 | 
15,000 | 
25,113 | 
| Repayments of long-term debt and redemption of bonds | 
-17,156 | 
-4,405 | 
-30,330 | 
-52,885 | 
-28,517 | 
| Other, net | 
-30,350 | 
-34,896 | 
-40,859 | 
-46,005 | 
-45,596 | 
| Net cash provided by (used in) financing activities | 
-39,520 | 
-42,894 | 
-77,193 | 
-45,867 | 
-86,246 | 
| Effect of exchange rate changes on cash and cash equivalents | 
680 | 
4,453 | 
3,210 | 
4,806 | 
637 | 
| Net increase (decrease) in cash and cash equivalents | 
11,569 | 
16,017 | 
-7,318 | 
-18,621 | 
-4,073 | 
| Cash and cash equivalents at beginning of year | 
63,746 | 
75,332 | 
91,350 | 
84,165 | 
65,543 | 
| Cash and cash equivalents of resulting from changes of consolidated subsidiaries | 
16 | 
 | 
 | 
 | 
1,205 | 
| Cash and cash equivalents of resulting from mergers with non-consolidated subsidiaries | 
 | 
 | 
132 | 
 | 
 | 
| Cash and cash equivalents at end of year | 
75,332 | 
91,350 | 
84,165 | 
65,543 | 
62,675 |